⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRVO News
CervoMed Inc. Common Stock
CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042
globenewswire.com
CRVO
Wall Street Chases the Next Big Breakout
globenewswire.com
CRVO
NTHI
SPCX
WULF
Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum
globenewswire.com
NTHI
CRVO
EWTX
Form 8-K
sec.gov
CRVO
CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies
globenewswire.com
CRVO
Form 8-K
sec.gov
CRVO
Form 8-K
sec.gov
CRVO
CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates
globenewswire.com
CRVO